AbbVie (ABBV) Net Cash Flow (2012 - 2026)

AbbVie (ABBV) has 15 years of Net Cash Flow data on file, last reported at $4.2 billion in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $4.2 billion, up 1265.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 billion (up 132.64% YoY), and the FY2025 annual result was -$337.0 million, up 95.34% from the prior year.
• Net Cash Flow climbed to $4.2 billion in Q1 2026 per ABBV's latest filing, from -$411.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $5.3 billion in Q1 2024 and troughed at -$5.9 billion in Q3 2024.
• A 5-year average of -$15.5 million and a median of -$411.0 million in 2025 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2026: Net Cash Flow tumbled 368.55% in 2022, then surged 1265.92% in 2026.
• A 5-year view of Net Cash Flow shows it stood at -$2.7 billion in 2022, then jumped by 81.31% to -$496.0 million in 2023, then sank by 240.12% to -$1.7 billion in 2024, then jumped by 75.64% to -$411.0 million in 2025, then surged by 1115.57% to $4.2 billion in 2026.
• Business Quant data shows ABBV's Net Cash Flow at $4.2 billion in Q1 2026, -$411.0 million in Q4 2025, and -$830.0 million in Q3 2025.